Mr. Damien McCallion:

I want to reinforce the important point that while we all accept that it is not a good position to have women waiting on the results, the clinical risk is very, very low in this context. Equally, we are focused on trying to resolve the backlog so that people who are waiting - we have made some inroads but not enough - are addressed through the capacity provision, and we will continue to look at all options as we get through this over the next while.